LIN CAO

OBJECTIVE: This study aimed to investigate the link between the inhibitory effect of ginsenoside Rg3 on the ectopic endometrium growth and the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, a mechanism known to inhibit angiogenesis and i…

In this study, the endometriosis rats model was randomly divided into 6 groups: model control group, ovariectomized group, Gestrinone group, and quercetin high/medium/low dose group. Rats were killed after 3 weeks of administration. The exp…

The development of new generation of progestin and anti-progestin compounds was reviewed in this paper.Based on R D achievements of new generation progestin and anti-progestin in recent years,we summarized the pharmacological effects and th…

OBJECTIVE: To investigate the effects of Caulis Sargentodoxae Granule (CSG), a compound traditional Chinese herbal medicine for treating endometriosis, on expressions of vascular endothelial growth factor (VEGF) and its receptor-2 fetal liv…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention pertains to the field of traditional Chinese medicine preparations, in particular to a medicine preparation for treating endometriosis and a preparation method thereof. The medicine preparation takes the traditional Chinese me…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…

The invention discloses a sustained-release microsphere to achieve the aims of contraception and long-term treatment of endometriosis uterine, which comprises the following components: (1) nomegestrol acetate or analogs thereof, and (2) a b…